Business Segments Immunovia AB London S.E.
Stocks
0G8X
SE0006091997
Advanced Medical Equipment & Technology
|
Market Closed -
London S.E.
10:45:34 2025-11-03 EST
|
After hours 11:25:00 | |||
| 31.92 SEK | -32.03% |
|
0.1580 | -99.51% |
| 09-03 | Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-01 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Medical Labs & Research | 844K | 1.14M | 1.58M | 931K | 685K | |||||
Total Assets | 494M | 301M | 98.68M | 33.04M | 88.21M | |||||
Interest Expense | -1.43M | -1.6M | -1.16M | -1.86M | -2.04M | |||||
Income Tax Expense | - | - | - | - | - | |||||
CAPEX | -24.18M | -1.62M | - | - | - | |||||
EBT | -156M | -168M | -309M | -76.54M | -146M | |||||
D&A | 11.82M | 12.5M | 133M | 25.42M | 1.66M | |||||
Operating Income | -167M | -191M | -296M | -109M | -80.38M | |||||
Net Income | -156M | -168M | -309M | -76.54M | -146M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Sweden | 844K | 1.14M | 1.58M | 931K | 685K | |||||
Total Assets | 494M | 301M | 98.68M | 33.04M | 88.21M | |||||
Interest Expense | -1.43M | -1.6M | -1.16M | -1.86M | -2.04M | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | 11.82M | 12.5M | 133M | 25.42M | 1.66M | |||||
CAPEX | -24.18M | -1.62M | - | - | - | |||||
Net Income | -156M | -168M | -309M | -76.54M | -146M | |||||
EBT | -156M | -168M | -309M | -76.54M | -146M | |||||
Operating Income | -167M | -191M | -296M | -109M | -80.38M |
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
- Financials Immunovia AB
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
